A Randomized Phase 2 Study of Paclitaxel and Carboplatin With or Without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer / Paz Ares, A; Bálint, B; de Boer, Rh; van Meerbeeck, Jp; Wierzbicki, R; De Souza, P; Galimi, Francesco; Haddad, V; Sabin, T; Hei, Y; Pan, Y; Cottrell, S; Hsu, Cp; Ramlau, R.. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - 8:3(2013), pp. 329-337. [10.1097/JTO.0b013e31827ce554]

A Randomized Phase 2 Study of Paclitaxel and Carboplatin With or Without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

GALIMI, Francesco;
2013

A Randomized Phase 2 Study of Paclitaxel and Carboplatin With or Without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer / Paz Ares, A; Bálint, B; de Boer, Rh; van Meerbeeck, Jp; Wierzbicki, R; De Souza, P; Galimi, Francesco; Haddad, V; Sabin, T; Hei, Y; Pan, Y; Cottrell, S; Hsu, Cp; Ramlau, R.. - In: JOURNAL OF THORACIC ONCOLOGY. - ISSN 1556-0864. - 8:3(2013), pp. 329-337. [10.1097/JTO.0b013e31827ce554]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/83919
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 54
  • ???jsp.display-item.citation.isi??? 52
social impact